Gain Therapeutics, Inc. (GANX) Misses Q2 EPS by 2c

Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
• Lazard Global Total Return fund declares $0.1534 monthly distribution